Advertisement

Sympathetic Ophthalmia

  • E. Clifford LazzaroEmail author
Chapter

Abstract

Sympathetic ophthalmia (SO) is an uncommon bilateral disorder following severe trauma to an eye. Uveal tract antigens leave the cloistered inside world of the eye and cause an autoimmune-like response which ultimately affects the uninjured (sympathizing) eye 5 days to 60 years later. SO causes a bilateral panuveitis and must be suspected when there is a uveitis in the contralateral eye of a severely injured fellow eye. Prompt diagnosis and treatment is necessary to preserve vision. In this chapter, we will discuss some illustrative cases and review the latest information about this sight threatening disorder.

Keywords

Sympathetic Ophthalmia Trauma Uveitis Antigen Immune Globe 

References

  1. 1.
    Serpell G. Sir William Mackenzie: sympathetic ophthalmia and glaucoma before ophthalmoscopy. ANZ J Surg. 2009;79:926–9 (Royal Australian College of Surgeons, Monash Medical Center Melbourne, Victoria, Australian).Google Scholar
  2. 2.
    Chin C, Whitcups S, Nussenblatt R. Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Syndrome Chapter 51 in Duane’s textbook of ophthalmology. 2010.Google Scholar
  3. 3.
    Chin C, Whitcups S, Nussenblatt R. Thirty two cases of sympathetic ophthalmia retrospective study at notional eye institute from 1982–1992. Arch Ophthalmol. 1995;113(5):579–600.Google Scholar
  4. 4.
    Albert DM, Diaz-Rohena R. A historical review of sympathetic ophthalmia and its epidemiology. Surv Ophthalmol. 1989;34:1–14.CrossRefPubMedGoogle Scholar
  5. 5.
    Chaithanyaa N, Devireddy S, Kumar K, Gali R, Aneja V. Sympathetic ophthalmia: a review of the literation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(2):172–6.CrossRefPubMedGoogle Scholar
  6. 6.
    O’Keefe S, Leng T. Sympathetic ophthalmia. American Academy Ophthalmology. 2014 Eye Wiki. Google Scholar
  7. 7.
    Chan CC, Benezra D, Rodriguez M, Hsu M, Palestine A, Murphee A, Nussenblatt R. Immunohistochemistry and microscopy of choroidal infiltration and Dalen-Fuchs nodules in sympathetic Ophthalmia. Ophthalmology. 1985;92(4):580–90.CrossRefPubMedGoogle Scholar
  8. 8.
    Davis J, Mittal K, Freidlin V, Mellow S, Optican D, Palestine A, Nussenblatt R. HLA association and ancestry in VKH disease and sympathetic ophthalmia. Ophthalmology. 1990;97(9):1137–42.CrossRefPubMedGoogle Scholar
  9. 9.
    Reynard M, Riffenburgh R, Minkler D. Morphologic variations of Dalen-Fuchs nodules in sympathetic ophthalmia. Br J Ophthalmol. 1985;69(3):197–201.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Gonzalez J, Chan C. Biopsy techniques ad yields in diagnosing primary intraocular lymphoma. Int Ophthalmol. 2007;27(4):241–50.CrossRefGoogle Scholar
  11. 11.
    Chin C, Nussenblatt RB, Fujikawa LS, Palestine A, Stevens G, Parver LM, Luckenbach M. Immunohistochemistry and election microscopy of choroidal infiltration and Dalen Fuchs nodules in sympathetic ophthalmia. Ophthalmology. 1985;92(4):580–90.CrossRefGoogle Scholar
  12. 12.
    De La Fuente MA, Alejandra N, Ferner P, Fernandez G, Sarasa J, Sanchez O. Sympathetic ophthalmia in HIV injection, a clinicopathologic case report. J Ophthalmia Inflammation Injection. 2012;2(3):161–4.CrossRefGoogle Scholar
  13. 13.
    Kozak Y, Sakai J, Thillaye B, Faure JP. S antigen—induced experimental autoimmune neuro-retinitis in rats. Current Eye Res. 1981;1(6):327–37.CrossRefGoogle Scholar
  14. 14.
    Schalkenm J, Winkens H, VanVugt H, DeGrip W, Broekhuyse R. Rhodopsin induced experimental autoimmune uveoretinitis in monkeys. Br J Ophthalmol. 1989;73(3):168–72.CrossRefGoogle Scholar
  15. 15.
    Grey I, Wiggert B, Redmond TM, Kuwabara, T. Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest Ophthalmol Vis Sci. 1986;27(8):1296–300.Google Scholar
  16. 16.
    Chu X, Chan C. Sympathetic ophthalmia: to the twenty first century and beyond. J Inflammation Infections. 2013;3(1):49. Google Scholar
  17. 17.
    Chan CC, Hikita N, Dastgheib K. Experimental melanin—protein-induced uveitis in the Lewis rat. Immunologic Process Ophthalmol. 1994;101(7):1275–1280.Google Scholar
  18. 18.
    Barker C, Billinghanic RE. Immunoloically privileged sites. Adv Immunol. 1977;25:1.Google Scholar
  19. 19.
    Chan C, Hakiti N, Dastgheib K, Whitcups S, Gray J, Nussenblatt R. Experimental melanin—protein induced uveitis in the Lewis Rat. Ophthalmology. 1994;101:1275–80.Google Scholar
  20. 20.
    Struyf S, Van Den Broeck C, Van Damme J, Opdenakker G, Geboes K, Kestelyn P. Expression of chemokines and gelatinase in sympathetic ophthalmia. Eye. 2007;3(5):649–57.Google Scholar
  21. 21.
    Parikh J, Saraswathy S, Rao N. Photoreceptor oxidative damage in sympathetic ophthalmia. Am J Ophthalmol. 2008;140(6):866–75.Google Scholar
  22. 22.
    Furusato E, Shine D, Cao X, Furusato B, Nussenblatt RB, Rushing E, Chan C. Inflammatory cytokine and chemokine expression in SO: pathology study. Histopathology. 2011;3(9):1145–51.Google Scholar
  23. 23.
    Arevalo J, Garcia R, Al-Dhibi H, Sanchez J. Update on sympathetic ophthalmia. Middle East Afr J Ophthalmol. 2012;19(1):13.Google Scholar
  24. 24.
    Phan L, Hwang T, McCulley T. Evisceration in the modern age. Middles East Afr J Ophthalmol. 2012;19(1):24.Google Scholar
  25. 25.
    Lubins J, Albert D, Weinstein M. Sixty five years of SO: a clinicopathologic rev. Ophthalmology. 1980;87:109–21.CrossRefGoogle Scholar
  26. 26.
    Chu D, Foster C. Sympathetic ophthalmia. Int Ophthalmol Clin. 2002;42(3):179–185. Google Scholar
  27. 27.
    Bilyk J. Enucleation, evisceration, and sympathetic ophthalmia. Curr Opin Ophthalmol. 2000;11(5):372–86.CrossRefPubMedGoogle Scholar
  28. 28.
    Yang C, Liu J. Chlorambucil therapy in sympathetic ophthalmia. Am J Ophthalmol. 1995;119(4):482–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Demico F, Kiss S, Young, L. Seminars in ophthalmology. 2005;20:191–197.Google Scholar
  30. 30.
    Pasadhika S, Rosenbaum J. Update on the use of systemic biological agents in the treatment of noninfectious uveitis. Biologics. 2014;8:67–81.Google Scholar
  31. 31.
    Myoung J, Asker G, Kiss S. Treatment of noninfectious positive uveitis with dexamethasone—intraocular implant. Clin Ophthalmol. 2010;4:1423–1426.Google Scholar
  32. 32.
    Castiblanco C, Adelman R. Imaging for SO: impact on diagnosis and management. Int Ophthalmol Clin. 2012;52(4):173–181.Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of OphthalmologyThe State University of New York (SUNY) Downstate Medical CenterBrooklynUSA

Personalised recommendations